Erratum to: Mutations of HNRNPA0 and WIF1 predispose members of a large family to multiple cancers - Chongjuan Wei; Bo Peng; Younghun Han; Wei V. Chen; Joshua Rother; Gail E. Tomlinson; C. Richard Boland; Damien Chaussabel; Marsha L. Frazier; Christopher I. Amos (Familial Cancer, 2015)

Mutations of HNRNPA0 and WIF1 predispose members of a large family to multiple cancers - Chongjuan Wei; Bo Peng; Younghun Han; Wei V. Chen; Joshua Rother; Gail E. Tomlinson; C. Richard Boland; Marc Chaussabel; Marsha L. Frazier; Christopher I. Amos (Familial Cancer, 2015)

Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk features - Paul A. James; Sarah Sawyer; Samantha Boyle; Mary-Anne Young; Serguei Kovalenko; Rebecca Doherty; Joanne McKinley; Kathryn Alsop; Victoria Beshay; Marion Harris; Stephen Fox; Geoffrey J. Lindeman; et al. (Familial Cancer, 2015)

Defective DNA mismatch repair activity is common in sebaceous neoplasms, and may be an ineffective approach to screen for Lynch syndrome - Anu R. Lamba; Angela Y. Moore; Todd Moore; Jennifer Rhees; Mildred A. Arnold; C. Richard Boland (Familial Cancer, 2015)

The effect of oral 3,3′-diindolylmethane supplementation on the 2:16α-OHE ratio in BRCA1 mutation carriers - Dina Nikitina; Marcia Llacuachaqui; Daniel Sepkovic; H. Leon Bradlow; Steven A. Narod; Joanne Kotsopoulos (Familial Cancer, 2015)

High-resolution melting (HRM) re-analysis of a polyposis patients cohort reveals previously undetected heterozygous and mosaic APC gene mutations - Astrid A. Out; Ivonne J. H. M. van Minderhout; Nienke van der Stoep; Lysette S. R. van Bommel; Irma Kluijt; Cora Aalfs; Marsha Voorendt; Rolf H. A. M. Vossen; Maartje Nielsen; Hans F. A. Vasen; Hans Morreau; Peter Devilee; et al. (Familial Cancer, 2015)

Germline RAD51B truncating mutation in a family with cutaneous melanoma - Karin A. W. Wadt; Lauren G. Aoude; Lisa Golmard; Thomas V. O. Hansen; Xavier Sastre-Garau; Nicholas K. Hayward; Anne-Marie Gerdes (Familial Cancer, 2015)

Exome sequencing reveals three novel candidate predisposition genes for diffuse gastric cancer - Iikki Donner; Tuula Kiviluoto; Ari Ristimäki; Lauri A. Aaltonen; Pia Vahteristo (Familial Cancer, 2015)

The breast cancer immunophenotype of TP53-p.R337H carriers is different from that observed among other pathogenic TP53 mutation carriers - Mariana Fitarelli-Kiehl; Juliana Giacomazzi; Patricia Santos-Silva; Marcia Silveira Graudenz; Edenir Inez Palmero; Rodrigo Augusto Depieri Michelli; Maria Isabel Achatz; Cynthia Aparecida Bueno de Toledo Osório; Victor Evangelista de Faria Ferraz; Clarissa Gondim Picanço; Patricia Ashton-Prolla (Familial Cancer, 2015)

A risk of digestive tract neoplasms susceptibility in miR-146a and miR-196a2 - Mingkun Xie; Yating Li; Jing Wu; Jin Wu (Familial Cancer, 2015)

Impact of BRCA1/2 mutation on young women’s 5-year parenthood rates: a prospective comparative study (GENEPSO-PS cohort) - Julien Mancini; Emmanuelle Mouret-Fourme; Catherine Noguès; Claire Julian-Reynier (Familial Cancer, 2015)

The roles of AXIN2 in tumorigenesis and epigenetic regulation - Shuang Li; Chunpeng Wang; Xiaodong Liu; Shucheng Hua; Xin Liu (Familial Cancer, 2015)

Comparison of proctocolectomy and ileal pouch-anal anastomosis to colectomy and ileorectal anastomosis in familial adenomatous polyposis - L. Koskenvuo; H. Mustonen; L. Renkonen-Sinisalo; H. J. Järvinen; A. Lepistö (Familial Cancer, 2015)

Parental age and Neurofibromatosis Type 1: a report from the NF1 Patient Registry Initiative - Qian Liu; Nancy Zoellner; David H. Gutmann; Kimberly J. Johnson (Familial Cancer, 2015)

Desmoid tumors: clinical features and outcome of an unpredictable and challenging manifestation of familial adenomatous polyposis - Fábio Guilherme Campos; Carlos Augusto Real Martinez; Marleny Novaes; Sérgio Carlos Nahas; Ivan Cecconello (Familial Cancer, 2015)

First-Line sunitinib in patients with renal cell carcinoma (RCC) in von Hippel–Lindau (VHL) disease: clinical outcome and patterns of radiological response - Anna Roma; Marco Maruzzo; Umberto Basso; Antonella Brunello; Rita Zamarchi; Elisabetta Bezzon; Fabio Pomerri; Stefania Zovato; Giuseppe Opocher; Vittorina Zagonel (Familial Cancer, 2015)

Health professionals’ evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer - Kirsten F. L. Douma; Bettina Meiser; Judy Kirk; Gillian Mitchell; Christobel Saunders; Belinda Rahman; Mariana S. Sousa; Kristine Barlow-Stewart; Margaret Gleeson; Kathy Tucker (Familial Cancer, 2015)

Gastric cancer in three relatives of a patient with a biallelic IL12RB1 mutation - Ingrid P. Vogelaar; Rachel S. van der Post; Esther van de Vosse; J. Han J. M. van Krieken; Nicoline Hoogerbrugge; Marjolijn J. L. Ligtenberg; Encarna Gómez García (Familial Cancer, 2015)

18th annual meeting: Collaborative Group of the Americas on Inherited Colorectal Cancer (CGA-ICC) (Familial Cancer, 2015)

Identification of a novel MSH6 germline variant in a family with multiple gastro-intestinal malignancies by next generation sequencing - Ashton A. Connor; Hagit Katzov-Eckert; Thomas Whelan; Melyssa Aronson; Lynette Lau; Christian Marshall; George S. Charames; Aaron Pollett; Steven Gallinger; Jordan Lerner-Ellis (Familial Cancer, 2015)

Population-based genetic risk prediction and stratification for ovarian cancer: views from women at high risk - Belinda Rahman; Susanne F. Meisel; Lindsay Fraser; Lucy Side; Sue Gessler; Jane Wardle; Anne Lanceley (Familial Cancer, 2015)

Estimate of the penetrance of BRCA mutation and the COS software for the assessment of BRCA mutation probability - Jacopo Berrino; Franco Berrino; Silvia Francisci; Bernard Peissel; Jacopo Azzollini; Valeria Pensotti; Paolo Radice; Patrizia Pasanisi; Siranoush Manoukian (Familial Cancer, 2015)

Single nucleotide polymorphisms in PDCD6 gene are associated with the development of cervical squamous cell carcinoma - Bin Zhou; Peng Bai; Hui Xue; Zhu Zhang; Shaoqing Shi; Kui Zhang; Yanyun Wang; Kana Wang; Yi Quan; Yaping Song; Lin Zhang (Familial Cancer, 2015)

Vestibular schwannoma in a patient with neurofibromatosis type 1: clinical report and literature review - Aamira Huq; Maira Kentwell; Amanda Tirimacco; Jacqueline Rossini; Lesley Rawlings; Ingrid Winship (Familial Cancer, 2015)

The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome - Ramona Moldovan; Sianan Keating; Tara Clancy (Familial Cancer, 2015)

Down-regulation of malignant potential by alpha linolenic acid in human and mouse colon cancer cells - John P. Chamberland; Hyun-Seuk Moon (Familial Cancer, 2015)

Desmoid tumour in familial adenomatous polyposis patients: responses to treatments - Thibault Desurmont; Jérémie H. Lefèvre; Conor Shields; Chrystelle Colas; Emmanuel Tiret; Yann Parc (Familial Cancer, 2015)

Multiple skin hamartomata: a possible novel clinical presentation of SUFU neoplasia syndrome - Kirsty Mann; Jill Magee; Marine Guillaud-Bataille; Christophe Blondel; Brigitte Bressac-de Paillerets; Josie Yeatman; Ingrid Winship (Familial Cancer, 2015)

Long-term outcomes of risk-reducing surgery in unaffected women at increased familial risk of breast and/or ovarian cancer - Louise Heiniger; Phyllis N. Butow; Joseph Coll; Tracey Bullen; Judy Wilson; Brandi Baylock; Bettina Meiser; Melanie A. Price (Familial Cancer, 2015)

Mitochondrial membrane potential and reactive oxygen species in cancer stem cells - Bei-bei Zhang; Dao-gang Wang; Fen-fen Guo; Chao Xuan (Familial Cancer, 2015)

Outcomes of genetic evaluation for hereditary cancer syndromes in unaffected individuals - Shanna L. Gustafson; Victoria M. Raymond; Monica L. Marvin; Tobias Else; Erika Koeppe; Elena M. Stoffel; Jessica N. Everett (Familial Cancer, 2015)

Familial and sporadic pancreatic cancer share the same molecular pathogenesis - Alexis L. Norris; Nicholas J. Roberts; Siân Jones; Sarah J. Wheelan; Nickolas Papadopoulos; Bert Vogelstein; Kenneth W. Kinzler; Ralph H. Hruban; Alison P. Klein; James R. Eshleman (Familial Cancer, 2015)

Further evidence for pathogenicity of the TP53 tetramerization domain mutation p.Arg342Pro in Li–Fraumeni syndrome - Anna Etzold; Julia C. Schröder; Oliver Bartsch; Ulrich Zechner; Danuta Galetzka (Familial Cancer, 2015)

MLH1 promotor hypermethylation does not rule out a diagnosis of Lynch syndrome: a case report - Victoria M. Raymond; Arden M. Morris; Khaled S. Hafez; Joel K. Greenson (Familial Cancer, 2015)

Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe - Natalia Bogdanova; Alexandr V. Togo; Magdalena Ratajska; Wojtek Kluźniak; Zalina Takhirova; Theresa Tarp; Darya Prokofyeva; Marina Bermisheva; Grigoriy A. Yanus; Tatiana V. Gorodnova; Anna P. Sokolenko; Alina Kuźniacka; et al. (Familial Cancer, 2015)

Mismatch repair deficient-crypts in non-neoplastic colonic mucosa in Lynch syndrome: insights from an illustrative case - Jinru Shia; Zsofia K. Stadler; Martin R. Weiser; Efsevia Vakiani; Robin Mendelsohn; Arnold J. Markowitz; Moshe Shike; C. Richard Boland; David S. Klimstra (Familial Cancer, 2015)

APC rearrangements in familial adenomatous polyposis: heterogeneity of deletion lengths and breakpoint sequences underlies similar phenotypes - Marialuisa Quadri; Annalisa Vetro; Viviana Gismondi; Monica Marabelli; Lucio Bertario; Paola Sala; Liliana Varesco; Orsetta Zuffardi; Guglielmina N. Ranzani (Familial Cancer, 2015)

Identification of a breast cancer family double heterozygote for RAD51C and BRCA2 gene mutations - Lise B. Ahlborn; Ane Y. Steffensen; Lars Jønson; Malene Djursby; Finn C. Nielsen; Anne-Marie Gerdes; Thomas V. O. Hansen (Familial Cancer, 2015)

Detection of inherited mutations for hereditary cancer using target enrichment and next generation sequencing - Yanfang Guan; Hong Hu; Yin Peng; Yuhua Gong; Yuting Yi; Libin Shao; Tengfei Liu; Gairui Li; Rongjiao Wang; Pingping Dai; Yves-Jean Bignon; Zhe Xiao; et al. (Familial Cancer, 2015)

Gly322Asp and Asn127Ser single nucleotide polymorphisms (SNPs) of hMSH2 mismatch repair gene and the risk of triple-negative breast cancer in Polish women - Beata Smolarz; Marianna Makowska; Dariusz Samulak; Magdalena M. Michalska; Hanna Romanowicz (Familial Cancer, 2015)

A polymorphism at miRNA-122-binding site in the IL-1α 3′UTR is associated with risk of epithelial ovarian cancer - Zhu Zhang; Bin Zhou; Qianqian Gao; Yuke Wu; Kui Zhang; Yan Pu; Yaping Song; Lin Zhang; Mingrong Xi (Familial Cancer, 2014)

Association of reduced XRCC2 expression with lymph node metastasis in breast cancer tissues - Nabiha Bashir; Syeda Sana; Ishrat Mahjabeen; Mahmood Akhtar Kayani (Familial Cancer, 2014)

Cancer genetic testing panels for inherited cancer susceptibility: the clinical experience of a large adult genetics practice - Christina G. Selkirk; Kristen J. Vogel; Anna C. Newlin; Scott M. Weissman; Shelly M. Weiss; Chi-Hsiung Wang; Peter J. Hulick (Familial Cancer, 2014)

High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registry - Christophe Rosty; Michael D. Walsh; Noralane M. Lindor; Stephen N. Thibodeau; Erin Mundt; Steven Gallinger; Melyssa Aronson; Aaron Pollett; John A. Baron; Sally Pearson; Mark Clendenning; Rhiannon J. Walters; et al. (Familial Cancer, 2014)

The secondary bile acid, deoxycholate accelerates intestinal adenoma–adenocarcinoma sequence in Apc min/+ mice through enhancing Wnt signaling - Hailong Cao; Shenhui Luo; Mengque Xu; Yujie Zhang; Shuli Song; Shan Wang; Xinyue Kong; Nana He; Xiaocang Cao; Fang Yan; Bangmao Wang (Familial Cancer, 2014)

Molecular heterogeneity of familial myeloproliferative neoplasms revealed by analysis of the commonly acquired JAK2, CALR and MPL mutations - Stephen E. Langabeer; Karl Haslam; Jennifer Linders; Melanie J. Percy; Eibhlin Conneally; Amjad Hayat; Brian Hennessy; Maeve Leahy; Karen Murphy; Margaret Murray; Fionnuala Ni Ainle; Patrick Thornton; et al. (Familial Cancer, 2014)

A primary care audit of familial risk in patients with a personal history of breast cancer - Paul Nathan; Aneeta Ahluwalia; Wendy Chorley (Familial Cancer, 2014)

High-resolution melting (HRM) assay for the detection of recurrent BRCA1/BRCA2 germline mutations in Tunisian breast/ovarian cancer families - Aouatef Riahi; Maher Kharrat; Imen Lariani; Habiba Chaabouni-Bouhamed (Familial Cancer, 2014)

Phenotype of SDHB mutation carriers in the Netherlands - Leonie T. van Hulsteijn; Nienke D. Niemeijer; Frederik J. Hes; Jean-Pierre Bayley; Carli M. Tops; Jeroen C. Jansen; Eleonora P. M. Corssmit (Familial Cancer, 2014)

Germline CDKN2A mutations in Brazilian patients of hereditary cutaneous melanoma - Alexandre Leon Ribeiro de Ávila; Ana Cristina Victorino Krepischi; Luciana Facure Moredo; Talita Ferreira Marques Aguiar; Felipe Carneiro da Silva; Bianca Costa Soares de Sá; Amanda França de Nóbrega; Maria Isabel Waddington Achatz; João Pedreira Duprat; Gilles Landman; Dirce Maria Carraro (Familial Cancer, 2014)

Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment - Fred H. Menko; Eamonn R. Maher; Laura S. Schmidt; Lindsay A. Middelton; Kristiina Aittomäki; Ian Tomlinson; Stéphane Richard; W. Marston Linehan (Familial Cancer, 2014)

“It’s all very well reading the letters in the genome, but it’s a long way to being able to write”: Men’s interpretations of undergoing genetic profiling to determine future risk of prostate cancer - Elizabeth K. Bancroft; Elena Castro; Audrey Ardern-Jones; Clare Moynihan; Elizabeth Page; Natalie Taylor; Rosalind A. Eeles; Emma Rowley; Karen Cox (Familial Cancer, 2014)

Muir–Torre syndrome or phenocopy? The value of the immunohistochemical expression of mismatch repair proteins in sebaceous tumors of immunocompromised patients - G. Ponti; G. Pellacani; C. Ruini; A. Percesepe; C. Longo; V. Desmond Mandel; F. Crucianelli; G. Gorelli; A. Tomasi (Familial Cancer, 2014)

Cribriform-morular variant of papillary thyroid carcinoma: an indication to screen for occult FAP - Rachel A. Levy; Vanessa W. Hui; Rupa Sood; Stephanie Fish; Arnold J. Markowitz; Richard J. Wong; José G. Guillem (Familial Cancer, 2014)

Association of interleukin-23 receptor gene polymorphisms with risk of bladder cancer in Chinese - Tielong Tang; Hui Xue; Shu Cui; Zhiyong Gong; Zhonghai Fei; Shulin Cheng; Chunyan Gui (Familial Cancer, 2014)

Genetic 135G/C polymorphism of RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls - Bei-bei Zhang; Dao-gang Wang; Chao Xuan; Gui-li Sun; Kai-feng Deng (Familial Cancer, 2014)

Rapid and cost effective screening of breast and ovarian cancer genes using novel sequence capture method in clinical samples - Kristóf Árvai; Péter Horváth; Bernadett Balla; Anna M. Tőkés; Bálint Tobiás; István Takács; Zsolt Nagy; Péter Lakatos; János P. Kósa (Familial Cancer, 2014)

Distinct gene expression profiles in ovarian cancer linked to Lynch syndrome - Jenny-Maria Jönsson; Katarina Bartuma; Mev Dominguez-Valentin; Katja Harbst; Zohreh Ketabi; Susanne Malander; Mats Jönsson; Ana Carneiro; Anna Måsbäck; Göran Jönsson; Mef Nilbert (Familial Cancer, 2014)

Erratum to: Frequency of 5382insC mutation of BRCA1 gene among breast cancer patients: an experience from Eastern India - Abhijit Chakraborty; Ashis Mukhopadhyay; Deboshree Bhattacharyya; Chinmoy Kr. Bose; Keya Choudhuri; Soma Mukhopadhyay; Jayasri Basak (Familial Cancer, 2014)

A survey of the practice patterns of gynecologic oncologists dealing with hereditary cancer patients in Japan - Noriko Tanabe; Ayumi Shikama; Hiroko Bando; Toyomi Satoh; Chikako Shimizu (Familial Cancer, 2014)

Genetics of endometrial cancer - Ayelet Shai; Yakir Segev; Steven A. Narod (Familial Cancer, 2014)

How harmful is genetic testing for familial adenomatous polyposis (FAP) in young children; the parents’ experience - Anna A. Kattentidt-Mouravieva; M. den Heijer; I. van Kessel; A. Wagner (Familial Cancer, 2014)

Nucleotide variants of the cancer predisposing gene CDH1 and the risk of non-syndromic cleft lip with or without cleft palate - Kamil K. Hozyasz; Adrianna Mostowska; Piotr Wójcicki; Agnieszka Lasota; Barbara Offert; Adam Balcerek; Izabella Dunin-Wilczyńska; Paweł P. Jagodziński (Familial Cancer, 2014)

“Would you test your children without their consent?” and other sticky dilemmas in the field of cancer genetic testing - Karina L. Brierley; Danielle C. Bonadies; Anne Moyer; Ellen T. Matloff (Familial Cancer, 2014)

A founder MLH1 mutation in Lynch syndrome families from Piedmont, Italy, is associated with an increased risk of pancreatic tumours and diverse immunohistochemical patterns - Iolanda Borelli; Guido C. Casalis Cavalchini; Serena Del Peschio; Monica Micheletti; Tiziana Venesio; Ivana Sarotto; Anna Allavena; Luisa Delsedime; Marco A. Barberis; Giorgia Mandrile; Paola Berchialla; Paola Ogliara; et al. (Familial Cancer, 2014)

Exploring the association of succinate dehydrogenase complex mutations with lymphoid malignancies - R. Renella; J. Carnevale; K. A. Schneider; J. L. Hornick; H. Q. Rana; K. A. Janeway (Familial Cancer, 2014)

Evaluating the utilization of educational materials in communicating about Lynch syndrome to at-risk relatives - Kristen Dilzell; Kerry Kingham; Kelly Ormond; Uri Ladabaum (Familial Cancer, 2014)

BRCA1 founder mutations compared to ovarian cancer in Belarus - Alena Savanevich; Oleg Oszurek; Jan Lubiński; Cezary Cybulski; Tadeusz Dębniak; Steven A. Narod; Jacek Gronwald (Familial Cancer, 2014)

An unusual case of familial adenomatous polyposis with very early symptom occurrence - Maurizio Ponz de Leon; Maria Anastasia Bianchini; Luca Reggiani-Bonetti; Monica Pedroni; Carmela Di Gregorio; Alberto Merighi; Giuseppina Rossi; Giulia Magnani; Federica Domati; Alfredo Cacciari (Familial Cancer, 2014)

BRCA1 point mutations in premenopausal breast cancer patients from Central Sudan - Ida Biunno; Gitana Aceto; Khalid Dafaallah Awadelkarim; Annalisa Morgano; Ahmed Elhaj; Elgaylani Abdalla Eltayeb; Dafalla Omer Abuidris; Nasr Eldin Elwali; Chiara Spinelli; Pasquale De Blasio; Ermanna Rovida; Renato Mariani-Costantini (Familial Cancer, 2014)

Influence of family history on psychosocial distress and perceived need for treatment in prostate cancer survivors - Andreas Dinkel; Marielouise Kornmayer; Jürgen E. Gschwend; Birgitt Marten-Mittag; Peter Herschbach; Kathleen Herkommer (Familial Cancer, 2014)

Fertility and apparent genetic anticipation in Lynch syndrome - Douglas Stupart; Aung Ko Win; Mark Jenkins; Ingrid M. Winship; Paul Goldberg; Rajkumar Ramesar (Familial Cancer, 2014)

Two Chinese pedigrees for adenomatous polyposis coli: new mutations at codon 1309 and predisposition to phenotypic variations - Dai-Xiang Liao; Bing Li; Xue-Mei Du; Jun-Hui Yu; Hong Chang; Zhi-Qiang Wu; Hao-Jie Hao; You-Xin Wang; Wei-Dong Han; Shu-jun Cheng; Cheng-Hua Luo (Familial Cancer, 2014)

Intronic splicing mutations in PTCH1 cause Gorlin syndrome - Zaynab Bholah; Miriam J. Smith; Helen J. Byers; Emma K. Miles; D. Gareth Evans; William G. Newman (Familial Cancer, 2014)

Analysis of patient reports on the referral process to two NSW cancer genetic services - Grace I. Butel-Simoes; Allan D. Spigelman (Familial Cancer, 2014)

Novel BRCA1 deleterious mutation (c.1918C>T) in familial breast and ovarian cancer syndrome who share a common ancestry - Xavier Gabaldó Barrios; María Desamparados Sarabia Meseguer; José Luis Alonso Romero; Miguel Marín Vera; Gema Marín Zafra; Pilar Sánchez Henarejos; Ana Isabel Sánchez Bermúdez; Francisco Ruiz Espejo (Familial Cancer, 2014)

A family history questionnaire improves detection of women at risk for hereditary gynecologic cancer: a pilot study - Margot M. Koeneman; Arnold-Jan Kruse; Simone J. S. Sep; Cynthia S. Gubbels; Brigitte F. M. Slangen; Toon van Gorp; Alberto Lopes; Encarna Gomez-Garcia; Roy F. P. M. Kruitwagen (Familial Cancer, 2014)

Limited diagnostic value of microsatellite instability associated pathology features in colorectal cancer - Paul G. van Putten; Margot G. F. van Lier; Mariska Hage; Katharina Biermann; Reinier H. van Rijssel; Pieter J. Westenend; Hans Morreau; Ewout W. Steyerberg; Winand N. M. Dinjens; Ernst J. Kuipers; Monique E. van Leerdam; J. Han van Krieken (Familial Cancer, 2014)

Attitudes and compliance of clinical management after genetic testing for hereditary breast and ovarian cancer among high-risk Southern Chinese females with breast cancer history - Ava Kwong; Annie Tsz-Wai Chu; Christine Teen-Sum Wu; Desiree Man-Sik Tse (Familial Cancer, 2014)

Mosaic partial deletion of the PTEN gene in a patient with Cowden syndrome - Erin E. Salo-Mullen; Jinru Shia; Isaac Brownell; Peter Allen; Monica Girotra; Mark E. Robson; Kenneth Offit; Jose G. Guillem; Arnold J. Markowitz; Zsofia K. Stadler (Familial Cancer, 2014)

Duplex value of caveolin-1 in non-small cell lung cancer: a meta analysis - Dali Chen; Cheng Shen; Heng Du; Yubin Zhou; Guowei Che (Familial Cancer, 2014)

Large genomic rearrangement of BRCA1 and BRCA2 genes in familial breast cancer patients in Korea - Ja Young Cho; Dae-Yeon Cho; Sei Hyun Ahn; Su-Youn Choi; Inkyung Shin; Hyun Gyu Park; Jong Won Lee; Hee Jeong Kim; Jong Han Yu; Beom Seok Ko; Bo Kyung Ku; Byung Ho Son (Familial Cancer, 2014)

Potential genetic anticipation in hereditary leiomyomatosis-renal cell cancer (HLRCC) - Mei Hua Wong; Chuen Seng Tan; Soo Chin Lee; Yvonne Yong; Aik Seng Ooi; Joanne Ngeow; Min Han Tan (Familial Cancer, 2014)

Providing patient education: impact on quantity and quality of family health history collection - Chris A. Beadles; R. Ryanne Wu; Tiffany Himmel; Adam H. Buchanan; Karen P. Powell; Elizabeth Hauser; Vincent C. Henrich; Geoffrey S. Ginsburg; Lori A. Orlando (Familial Cancer, 2014)

Capsule endoscopy versus magnetic resonance enterography for the detection of small bowel polyps in Peutz–Jeghers syndrome - P. Urquhart; F. Grimpen; G. J. Lim; C. Pizzey; D. L. Stella; P. A. Tesar; F. A. Macrae; M. A. Appleyard; G. J. Brown (Familial Cancer, 2014)

The MUTYH hotspot mutations p.G396D and p.Y179C do not cause substantial genetic susceptibility to biliary cancer - M. Casper; M. Acalovschi; F. Lammert; V. Zimmer (Familial Cancer, 2014)

Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations—a clinical observational study - Linda Bardram; Thomas V. O. Hansen; Anne-Marie Gerdes; Susanne Timshel; Lennart Friis-Hansen; Birgitte Federspiel (Familial Cancer, 2014)

Baseline and post prophylactic tubal–ovarian surgery CA125 levels in BRCA1 and BRCA2 mutation carriers - Ying Chen; Elizabeth Bancroft; Sue Ashley; Audrey Arden-Jones; Sarah Thomas; Susan Shanley; Sibel Saya; Emma Wakeling; Rosalind Eeles (Familial Cancer, 2014)

Attitudes and knowledge of medical practitioners to hereditary cancer clinics and cancer genetic testing - Ian Teng; Allan Spigelman (Familial Cancer, 2014)

Breast cancer risk assessment in 8,824 women attending a family history evaluation and screening programme - D. Gareth R. Evans; Sarah Ingham; Sarah Dawe; L. Roberts; F. Lalloo; A. R. Brentnall; P. Stavrinos; Anthony Howell (Familial Cancer, 2014)

Evaluation after five years of the cancer genetic counselling programme of Valencian Community (Eastern Spain) - Dolores Cuevas-Cuerda; Dolores Salas-Trejo (Familial Cancer, 2014)

Ectopic Cushing syndrome associated with thymic carcinoid tumor as the first presentation of MEN1 syndrome-report of a family with MEN1 gene mutation - Shirin Hasani-Ranjbar; Masoud Rahmanian; Azadeh Ebrahim-Habibi; Akbar Soltani; Akbar Soltanzade; Elnaz Mahrampour; Mahsa M. Amoli (Familial Cancer, 2014)

A randomized controlled trial of diet and physical activity in BRCA mutation carriers - P. Pasanisi; E. Bruno; S. Manoukian; F. Berrino (Familial Cancer, 2014)

Inversion of exons 1–7 of the MSH2 gene is a frequent cause of unexplained Lynch syndrome in one local population - Jennifer Rhees; Mildred Arnold; C. Richard Boland (Familial Cancer, 2014)

RAD51 135G>C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women - Ana M. Krivokuca; Emina J. Malisic; Jelena D. Dobricic; Ksenija V. Brotto; Milena R. Cavic; Radmila N. Jankovic; Zorica I. Tomasevic; Mirjana V. Brankovic-Magic (Familial Cancer, 2014)

Impact of familial risk and mammography screening on prognostic indicators of breast disease among women from the Ontario site of the Breast Cancer Family Registry - Meghan J. Walker; Lucia Mirea; Kristine Cooper; Mitra Nabavi; Gord Glendon; Irene L. Andrulis; Julia A. Knight; Frances P. O’Malley; Anna M. Chiarelli (Familial Cancer, 2014)

Misperceptions of ovarian cancer risk in women at increased risk for hereditary ovarian cancer - Bettina Meiser; Melanie A. Price; Phyllis N. Butow; Belinda Rahman; Kathy Tucker; Benjamin Cheah; Adrian Bickerstaffe; John Hopper; Kelly-Anne Phillips (Familial Cancer, 2014)

Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromes - Thereasa A. Rich; Mei Liu; Carol J. Etzel; Sarah A. Bannon; Maureen E. Mork; Kaylene Ready; Devki S. Saraiya; Elizabeth G. Grubbs; Nancy D. Perrier; Karen H. Lu; Banu K. Arun; Terri L. Woodard; et al. (Familial Cancer, 2014)

Prevalence of PALB2 mutation c.509_510delGA in unselected breast cancer patients from Central and Eastern Europe - Monika Noskowicz; Natalia Bogdanova; Marina Bermisheva; Zalina Takhirova; Natalia Antonenkova; Elza Khusnutdinova; Michael Bremer; Hans Christiansen; Tjoung-Won Park-Simon; Peter Hillemanns; Thilo Dörk (Familial Cancer, 2014)

Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families - Kory W. Jasperson; Wendy Kohlmann; Amanda Gammon; Heidi Slack; Luke Buchmann; Jason Hunt; Anne C. Kirchhoff; Henry Baskin; Akram Shaaban; Joshua D. Schiffman (Familial Cancer, 2014)

Barrett’s esophagus in the patients with familial adenomatous polyposis - Zoran Gatalica; Mingkui Chen; Carrie Snyder; Sumeet Mittal; Henry T. Lynch (Familial Cancer, 2014)

Diversity of the clinical presentation of the MMR gene biallelic mutations - Gaëlle Bougeard; Laurence Olivier-Faivre; Stéphanie Baert-Desurmont; Julie Tinat; Cosette Martin; Emilie Bouvignies; Stéphanie Vasseur; Frédéric Huet; Gérard Couillault; Pierre Vabres; Florence Le Pessot; Caroline Chapusot; et al. (Familial Cancer, 2014)

Genetic variation at 8q24, family history of cancer, and upper gastrointestinal cancers in a Chinese population - Heather P. Tarleton; Shen-Chih Chang; Sungshim Lani Park; Lin Cai; Baoguo Ding; Na He; Shehnaz K. Hussain; Qingwu Jiang; Li-Na Mu; Jianyu Rao; Hua Wang; Nai-Chieh Y. You; et al. (Familial Cancer, 2014)

Cancer risk and overall survival in mismatch repair proficient hereditary non-polyposis colorectal cancer, Lynch syndrome and sporadic colorectal cancer - Pilar Garre; Lorena Martín; Inmaculada Bando; Alicia Tosar; Patricia Llovet; Julián Sanz; Atocha Romero; Miguel de la Hoya; Eduardo Díaz-Rubio; Trinidad Caldés (Familial Cancer, 2014)

Impact of breast cancer family history on tumor detection and tumor size in women newly-diagnosed with invasive breast cancer - Fabienne Dominique Schwab; Nicole Bürki; Dorothy Jane Huang; Viola Heinzelmann-Schwarz; Seraina Margaretha Schmid; Marcus Vetter; Andreas Schötzau; Uwe Güth (Familial Cancer, 2014)

Reflex testing for Lynch syndrome: If we build it, will they come? Lessons learned from the uptake of clinical genetics services by individuals with newly diagnosed colorectal cancer (CRC) - E. Tomiak; A. Samson; N. Spector; M. Mackey; C. Gilpin; E. Smith; D. Jonker; J. Allanson; T. Asmis (Familial Cancer, 2014)

Lack of association between let-7 binding site polymorphism rs712 and risk of nasopharyngeal carcinoma - Xin-Min Pan; Jing Jia; Xiao-Min Guo; Zhao-Hui Li; Zhen Zhang; Hao-Jie Qin; Guo-Hui Xu; Lin-Bo Gao (Familial Cancer, 2014)

Lynch Syndrome in high risk Ashkenazi Jews in Israel - Yael Goldberg; Inbal Kedar; Revital Kariiv; Naama Halpern; Morasha Plesser; Ayala Hubert; Luna Kaduri; Michal Sagi; Israela Lerer; Dvorah Abeliovich; Tamar Hamburger; Aviram Nissan; et al. (Familial Cancer, 2014)

Illness perceptions, risk perception and worry in SDH mutation carriers - L. T. van Hulsteijn; A. A. Kaptein; A. Louisse; N. R. Biermasz; J. W. A. Smit; E. P. M. Corssmit (Familial Cancer, 2014)

Does and should breast cancer genetic counselling include lifestyle advice? - Akke Albada; Madelèn Vernooij; Liesbeth van Osch; Anouk Pijpe; Sandra van Dulmen; Margreet G. E. M. Ausems (Familial Cancer, 2014)

Cancer risk and genotype–phenotype correlations in PTEN hamartoma tumor syndrome - Marry H. Nieuwenhuis; C. Marleen Kets; Maureen Murphy-Ryan; Helger G. Yntema; D. Gareth Evans; Chrystelle Colas; Pal Møller; Frederik J. Hes; Shirley V. Hodgson; Maran J. W. Olderode-Berends; Stefan Aretz; Karl Heinimann; et al. (Familial Cancer, 2014)

The MDM2 285G–309G haplotype is associated with an earlier age of tumour onset in patients with Li-Fraumeni syndrome - Mariette Renaux-Petel; Richard Sesboüé; Stéphanie Baert-Desurmont; Stéphanie Vasseur; Steeve Fourneaux; Emilie Bessenay; Thierry Frébourg; Gaëlle Bougeard (Familial Cancer, 2014)

Endometrial tumour BRAF mutations and MLH1 promoter methylation as predictors of germline mismatch repair gene mutation status: a literature review - Alexander M. Metcalf; Amanda B. Spurdle (Familial Cancer, 2014)

No evidence of genetic anticipation in a large family with Lynch syndrome - D. Stupart; P. Goldberg; U. Algar; A. Vorster; R. Ramesar (Familial Cancer, 2014)

The prevalence of small intestinal polyps in patients with familial adenomatous polyposis: a prospective capsule endoscopy study - Atsuo Yamada; Hirotsugu Watabe; Takeo Iwama; Shuntaro Obi; Masao Omata; Kazuhiko Koike (Familial Cancer, 2014)

MAX mutations status in Swedish patients with pheochromocytoma and paraganglioma tumours - Joakim Crona; Rajani Maharjan; Alberto Delgado Verdugo; Peter Stålberg; Dan Granberg; Per Hellman; Peyman Björklund (Familial Cancer, 2014)

Mammographic surveillance in women aged 35–39 at enhanced familial risk of breast cancer (FH02) - D. G. Evans; S. Thomas; J. Caunt; L. Roberts; A. Howell; M. Wilson; R. Fox; D. M. Sibbering; S. Moss; M. G. Wallis; D. M. Eccles; S. Duffy (Familial Cancer, 2014)

Deletion of exons 1–3 of the MEN1 gene in a large Italian family causes the loss of menin expression - Maria Chiara Zatelli; Federico Tagliati; Mauro Di Ruvo; Emilie Castermans; Luigi Cavazzini; Adrian F. Daly; Maria Rosaria Ambrosio; Albert Beckers; Ettore degli Uberti (Familial Cancer, 2014)

Is intraductal tubulopapillary neoplasia a new entity in the spectrum of familial pancreatic cancer syndrome? - Marco Del Chiaro; Raffaella Pozzi Mucelli; John Blomberg; Ralf Segersvärd; Caroline Verbeke (Familial Cancer, 2013)

Chemoprevention in Lynch syndrome - John Burn; John C. Mathers; D. Tim Bishop (Familial Cancer, 2013)

Whole exome sequencing identifies mutation of EDNRA involved in ACTH-independent macronodular adrenal hyperplasia - Jie Zhu; Liang Cui; Wei Wang; Xing-Yi Hang; A-Xiang Xu; Su-Xia Yang; Jing-Tao Dou; Yi-Ming Mu; Xu Zhang; Jiang-Ping Gao (Familial Cancer, 2013)

Polymorphisms in arachidonic acid metabolism-related genes and the risk and prognosis of colorectal cancer - Shuying Li; Xiaojuan Zhao; Zhiwei Wu; Ye Li; Lin Zhu; Binbin Cui; Xinshu Dong; Suli Tian; Fulan Hu; Yashuang Zhao (Familial Cancer, 2013)

Multivariate analysis of MLH1 c.1664T>C (p.Leu555Pro) mismatch repair gene variant demonstrates its pathogenicity - M. P. Farrell; D. J. Hughes; M. Drost; A. J. Wallace; R. J. Cummins; T. A. Fletcher; M. A. Meany; E. W. Kay; N. de Wind; D. G. Power; E. J. Andrews; A. J. Green; et al. (Familial Cancer, 2013)

Rectal cancers in patients with familial adenomatous polyposis - Jennifer Liang; James M. Church (Familial Cancer, 2013)

Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry - Murray Joseph Casey; Chhanda Bewtra; Henry T. Lynch; Carrie Snyder; Mark Stacy; Patrice Watson (Familial Cancer, 2013)

“High rate of recurrent adenomatosis during endoscopic surveillance after duodenectomy in patients with familial adenomatous polyposis” - Yasser A. Alderlieste; Barbara A. Bastiaansen; Elisabeth M. H. Mathus-Vliegen; Dirk J. Gouma; Evelien Dekker (Familial Cancer, 2013)

Association of the BRCA1 promoter polymorphism rs11655505 with the risk of familial breast and/or ovarian cancer - Beata Bielinska; Pawel Gaj; Anna Kluska; Dorota Nowakowska; Aneta Balabas; Michalina Dabrowska; Anna Niwinska; Jakub Gruchota; Renata Zub; Elzbieta Skasko; Jan Steffen; Jerzy Ostrowski; et al. (Familial Cancer, 2013)

Underestimated survival predictions of the prognostic tools Adjuvant! Online and PREDICT in BRCA1-associated breast cancer patients - Grigorijs Plakhins; Arvids Irmejs; Andris Gardovskis; Signe Subatniece; Inta Liepniece-Karele; Gunta Purkalne; Uldis Teibe; Genadijs Trofimovics; Edvins Miklasevics; Janis Gardovskis (Familial Cancer, 2013)

The Proceedings of the Collaborative Group of the Americas on Inherited Colorectal Cancer Sheraton Boston Hotel, Boston, Massachusetts, October 27–29, 2012 (Familial Cancer, 2013)

Can we test for hereditary cancer at 18 years when we start surveillance at 25? Patient reported outcomes - Aisha S. Sie; Judith B. Prins; Liesbeth Spruijt; C. Marleen Kets; Nicoline Hoogerbrugge (Familial Cancer, 2013)

Case report: metachronous central nervous system desmoid tumours and thyroid carcinoma in a young familial adenomatous polyposis patient - G. I. Butel-Simoes; A. D. Spigelman (Familial Cancer, 2013)

Extracolonic cancer risk in patients with serrated polyposis syndrome and their first-degree relatives - Yark Hazewinkel; Johannes B. Reitsma; Fokko M. Nagengast; Hans F. Vasen; Theo A. M. van Os; Monique E. van Leerdam; Jan-Jacob Koornstra; Evelien Dekker (Familial Cancer, 2013)

Self administered screening for hereditary cancers in conjunction with mammography and ultrasound - Charles H. McDonnell; David J. Seidenwurm; Diana E. McDonnell; Kristie A. Bobolis (Familial Cancer, 2013)

Do individuals with a family history of colorectal cancer adhere to medical recommendations for the prevention of colorectal cancer? - Karen Bronner; Ilse Mesters; Ahuva Weiss-Meilnik; Ravit Geva; Guy Rozner; Hana Strul; Moshe Inbar; Zamir Halpern; Revital Kariv (Familial Cancer, 2013)

Psychosocial consequences of predictive genetic testing for lynch syndrome and associations to surveillance behaviour in a 7-year follow-up study - Katja Aktan-Collan; Helena Kääriäinen; Heikki Järvinen; Päivi Peltomäki; Kirsi Pylvänäinen; Jukka-Pekka Mecklin; Ari Haukkala (Familial Cancer, 2013)

Interest of individuals from BRCA families to participate in research studies focused on male BRCA carriers - Tuya Pal; Susan Vadaparampil; Jongphil Kim; Yan Xu; Sue Friedman; Steven A. Narod; Kelly Metcalfe (Familial Cancer, 2013)

Factors affecting the decision to undergo risk-reducing salpingo-oophorectomy among women with BRCA gene mutation - Dongwon Kim; Eunyoung Kang; Euijun Hwang; Young Sun; Yoonsun Hwang; Cha Kyong Yom; Kidong Kim; Jae Hong No; Yong-Beom Kim; Sung-Won Kim (Familial Cancer, 2013)

Frameshift mutation in the PTCH2 gene can cause nevoid basal cell carcinoma syndrome - Katsunori Fujii; Hirofumi Ohashi; Maiko Suzuki; Hiromi Hatsuse; Tadashi Shiohama; Hideki Uchikawa; Toshiyuki Miyashita (Familial Cancer, 2013)

Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalence - Inmaculada de Juan Jiménez; Zaida García Casado; Sarai Palanca Suela; Eva Esteban Cardeñosa; José Antonio López Guerrero; Ángel Segura Huerta; Isabel Chirivella González; Ana Beatriz Sánchez Heras; Mª José Juan Fita; Isabel Tena García; Carmen Guillen Ponce; Eduardo Martínez de Dueñas; et al. (Familial Cancer, 2013)

Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer - Shaheen Alanee; Sohela Shah; Joseph Vijai; Kasmintan Schrader; Robert Hamilton; Rohini Rau-Murthy; Kara Sarrel; Christopher Manschreck; James Eastham; Kenneth Offit (Familial Cancer, 2013)

Is the psychological impact of genetic testing moderated by support and sharing of test results to family and friends? - Julie Lapointe; Michel Dorval; Catherine Noguès; Roxane Fabre; Claire Julian-Reynier (Familial Cancer, 2013)

The incidence of PALB2 c.3113G>A in women with a strong family history of breast and ovarian cancer attending familial cancer centres in Australia - Zhi L. Teo; Sarah D. Sawyer; Paul A. James; Gillian Mitchell; Alison H. Trainer; Geoffrey J. Lindeman; Kylie Shackleton; Linda Cicciarelli; Melissa C. Southey (Familial Cancer, 2013)

More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling - Aisha S. Sie; Wendy A. G. van Zelst-Stams; Liesbeth Spruijt; Arjen R. Mensenkamp; Marjolijn J. L. Ligtenberg; Han G. Brunner; Judith B. Prins; Nicoline Hoogerbrugge (Familial Cancer, 2013)

Birt–Hogg–Dubé syndrome - Maria F. Czyzyk-Krzeska; Francis X. McCormack (Familial Cancer, 2013)

Abstracts (Familial Cancer, 2013)

Erratum to: Birt–Hogg–Dubé: beyond the clinical manifestations - Lindsay A. Middelton (Familial Cancer, 2013)

Pulmonary manifestations of Birt-Hogg-Dubé syndrome - Nishant Gupta; Kuniaki Seyama; Francis X. McCormack (Familial Cancer, 2013)

Diagnosis and management of BHD-associated kidney cancer - Lambros Stamatakis; Adam R. Metwalli; Lindsay A. Middelton; W. Marston Linehan (Familial Cancer, 2013)

Screening participation for people at increased risk of colorectal cancer due to family history: a systematic review and meta-analysis - Driss Ait Ouakrim; Trevor Lockett; Alex Boussioutas; John L. Hopper; Mark A. Jenkins (Familial Cancer, 2013)

Clinical characterization and mutation spectrum in Hispanic families with adenomatous polyposis syndromes - Marcia Cruz-Correa; Yaritza Diaz-Algorri; Vanessa Mendez; Pedro Juan Vazquez; Maria Eugenia Lozada; Katerina Freyre; Liselle Lathroum; Maria Gonzalez-Pons; Jessica Hernandez-Marrero; Francis Giardiello; Segundo Rodriguez-Quilichini (Familial Cancer, 2013)

Mutation screen and RNA analysis disclose the changed splicing of the E-cadherin transcription in gastric cancer - Xiaowei Li; Yafan Gao; Yiyuan Pan; Yan Pan; Lifeng Wang; Nong Xiao; Qiong He; Yimei Fan; Yaping Wang (Familial Cancer, 2013)

Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial - Susan V. Montgomery; Andrea M. Barsevick; Brian L. Egleston; Ruth Bingler; Karen Ruth; Suzanne M. Miller; John Malick; Terrence P. Cescon; Mary B. Daly (Familial Cancer, 2013)

Mutation screening in a Norwegian cohort with pheochromocytoma - Wenche Sjursen; Henrik Halvorsen; Eva Hofsli; Siri Bachke; Åsa Berge; Lars F. Engebretsen; Sture E. Falkmer; Ursula G. Falkmer; Jan E. Varhaug (Familial Cancer, 2013)

Familial adenomatous polyposis: not all masses are desmoids - J. Sloane; P. Ranchod; G. Williams; S. K. Clark (Familial Cancer, 2013)

The prognostic value of MGMT promoter methylation in Glioblastoma multiforme: a meta-analysis - Kui Zhang; Xiao-qin Wang; Bin Zhou; Lin Zhang (Familial Cancer, 2013)

Detection of large deletions in the VHL gene using a Real-Time PCR with SYBR Green - Andrew Ebenazer; Simon Rajaratnam; Rekha Pai (Familial Cancer, 2013)

Erratum to: Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis - Kory W. Jasperson; Thuy M. Vu; Angela L. Schwab; Deborah W. Neklason; Miguel A. Rodriguez-Bigas; Randall W. Burt; Jeffrey N. Weitzel (Familial Cancer, 2013)

Erratum to: Closing the loop: an interactive action research conference format for delivering updated medical information while eliciting Latina patient/family experiences and psychosocial needs post-genetic cancer risk assessment - Deborah J. MacDonald; Julia Deri; Charité Ricker; Martin A. Perez; Raquel Ogaz; Nancy Feldman; Lori A. Viveros; Benjamin Paz; Jeffrey N. Weitzel; Kathleen R. Blazer (Familial Cancer, 2013)

GNAS is not involved in gastrointestinal tumour formation in Peutz-Jeghers syndrome - Susanne E. Korsse; Maikel P. Peppelenbosch; Ron Smits; Wendy van Veelen (Familial Cancer, 2013)

Splice site mutations in mismatch repair genes and risk of cancer in the general population - Mette Thomsen; Børge G. Nordestgaard; Anne Tybjærg-Hansen; Stig E. Bojesen (Familial Cancer, 2013)

Birt–Hogg–Dubé syndrome and the skin - Marigje Vernooij; Tijs Claessens; Monique Luijten; Maurice A. M. van Steensel; Barry J. Coull (Familial Cancer, 2013)

Erratum to: Birt–Hogg–Dubé syndrome: from gene discovery to molecularly targeted therapies - Laura S. Schmidt (Familial Cancer, 2013)

The risk of gastric cancer in carriers of CHEK2 mutations - Urszula Teodorczyk; Cezary Cybulski; Dominika Wokołorczyk; Anna Jakubowska; Teresa Starzyńska; Małgorzata Ławniczak; Paweł Domagała; Katarzyna Ferenc; Krzysztof Marlicz; Zbigniew Banaszkiewicz; Rafał Wiśniowski; Steven A. Narod; et al. (Familial Cancer, 2013)

Detection of large scale 3′ deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything? - Mark Clendenning; Michael D. Walsh; Judith Balmana Gelpi; Stephen N. Thibodeau; Noralane Lindor; John D. Potter; Polly Newcomb; Loic LeMarchand; Robert Haile; Steve Gallinger; John L. Hopper; Mark A. Jenkins; et al. (Familial Cancer, 2013)

Unmet support needs and distress among women with a BRCA1/2 mutation - Ashley Farrelly; Victoria White; Bettina Meiser; Michael Jefford; Mary-Anne Young; Sandra Ieropoli; Ingrid Winship; Jessica Duffy (Familial Cancer, 2013)

A de novo FLCN mutation in a patient with spontaneous pneumothorax and renal cancer; a clinical and molecular evaluation - Fred H. Menko; Paul C. Johannesma; R. Jeroen A. van Moorselaar; Rinze Reinhard; Jan Hein van Waesberghe; Erik Thunnissen; Arjan C. Houweling; Edward M. Leter; Quinten Waisfisz; Martijn B. van Doorn; Theo M. Starink; Pieter E. Postmus; et al. (Familial Cancer, 2013)

Searching for E-cadherin gene mutations in early onset diffuse gastric cancer and hereditary diffuse gastric cancer in Korean patients - Sollip Kim; Jun-Won Chung; Tae-Dong Jeong; Young-Soo Park; Jeong Hoon Lee; Ji Yong Ahn; Do Hoon Kim; Kee Don Choi; Woochang Lee; Ho June Song; Gin Hyug Lee; Sail Chun; et al. (Familial Cancer, 2013)

A complex endocrine conundrum - G. Bano; V. Siedel; N. Beharry; P. Wilson; T. Cranston; S. Hodgson (Familial Cancer, 2013)

Cancer family history triage: a key step in the decision to offer screening and genetic testing - Paul Brennan; Oonagh Claber; Tracey Brennan (Familial Cancer, 2013)

Frequency of 5382insC mutation of BRCA1 gene among breast cancer patients: an experience from Eastern India - Abhijit Chakraborty; Ashis Mukhopadhyay; Deboshree Bhattacharyya; Chinmoy Kr. Bose; Keya Choudhuri; Soma Mukhopadhyay; Jayasri Basak (Familial Cancer, 2013)

Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer - Jessica P. Gopie; Marc A. M. Mureau; Caroline Seynaeve; Moniek M. ter Kuile; Marian B. E. Menke-Pluymers; Reinier Timman; Aad Tibben (Familial Cancer, 2013)

A case of pneumatosis cystoides intestinalis mimicking familial adenomatous polyposis - Maurizio Ponz de Leon; Claudia Bertarelli; Gian Piero Casadei; Andrea Grilli; Patrizia Bacchini; Monica Pedroni; Elio Jovine (Familial Cancer, 2013)

Birt–Hogg–Dubé syndrome: from gene discovery to molecularly targeted therapies - Laura S. Schmidt (Familial Cancer, 2013)

Birt–Hogg–Dubé: tumour suppressor function and signalling dynamics central to folliculin - Andrew R. Tee; Arnim Pause (Familial Cancer, 2013)

InSiGHT, pedigree, familial aspects of cancer and the Human Variome Project in conjunction with the COSA familial cancer group (Familial Cancer, 2013)

Endometrial and ovarian cancer in women with Lynch syndrome: update in screening and prevention - Karen H. Lu; Molly Daniels (Familial Cancer, 2013)

Towards a vaccine to prevent cancer in Lynch syndrome patients - Magnus von Knebel Doeberitz; Matthias Kloor (Familial Cancer, 2013)

Surveillance for urinary tract cancer in Lynch syndrome - Inge Thomsen Bernstein; Torben Myrhøj (Familial Cancer, 2013)

Value-based healthcare in Lynch syndrome - Simone D. Hennink; Nandy Hofland; Jessica P. Gopie; Corinne van der Kaa; Kimberley de Koning; Maartje Nielsen; Carli Tops; Hans Morreau; Wouter H. de Vos tot Nederveen Cappel; Alexandra M. J. Langers; James C. Hardwick; Katja N. Gaarenstroom; et al. (Familial Cancer, 2013)

100 years lynch syndrome: what have we learned about psychosocial issues? - Eveline M. A. Bleiker; Mary Jane Esplen; Bettina Meiser; Helle Vendel Petersen; Andrea Farkas Patenaude (Familial Cancer, 2013)

A hundred years of Lynch syndrome research (1913–2013) - Hans F. A. Vasen; Wouter H. de Vos tot Nederveen Cappel (Familial Cancer, 2013)

Foreword for “100 years of Lynch syndrome” - Henry T. Lynch; Patrick M. Lynch (Familial Cancer, 2013)

Do lifestyle factors influence colorectal cancer risk in Lynch syndrome? - Fränzel J. B. van Duijnhoven; Akke Botma; Renate Winkels; Fokko M. Nagengast; Hans F. A. Vasen; Ellen Kampman (Familial Cancer, 2013)

Cancer risk in Lynch Syndrome - Emma Barrow; James Hill; D. Gareth Evans (Familial Cancer, 2013)

The mechanism of mismatch repair and the functional analysis of mismatch repair defects in Lynch syndrome - Juana V. Martín-López; Richard Fishel (Familial Cancer, 2013)

How do we approach the goal of identifying everybody with Lynch Syndrome? - Heather Hampel; Albert de la Chapelle (Familial Cancer, 2013)

Prediction models in Lynch syndrome - Fay Kastrinos; Judith Balmaña; Sapna Syngal (Familial Cancer, 2013)

The History of Lynch Syndrome - C. Richard Boland; Henry T. Lynch (Familial Cancer, 2013)

Chemotherapy of MMR-deficient colorectal cancer - N. Devaud; S. Gallinger (Familial Cancer, 2013)

Informing family members of individuals with Lynch syndrome: a guideline for clinical geneticists - Fred H. Menko; Cora M. Aalfs; Lidewij Henneman; Yrrah Stol; Miranda Wijdenes; Ellen Otten; Marleen M. J. Ploegmakers; Johan Legemaate; Ellen M. A. Smets; Guido M. W. R. de Wert; Aad Tibben (Familial Cancer, 2013)

Lynch syndrome: the patients perspective - Jurgen Seppen; Linda Bruzzone (Familial Cancer, 2013)

Colorectal surveillance in Lynch syndrome families - Wouter H. de Vos tot Nederveen Cappel; Heikki J. Järvinen; Patrick M. Lynch; Christoph Engel; Jukka-Pekka Mecklin; Hans F. A. Vasen (Familial Cancer, 2013)

Gene variants of unknown clinical significance in Lynch syndrome. An introduction for clinicians - Rolf H. Sijmons; Marc S. Greenblatt; Maurizio Genuardi (Familial Cancer, 2013)

Surgical treatment of hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) - Miguel A. Rodriguez-Bigas; Gabriela Möeslein (Familial Cancer, 2013)

Genetic modifiers of cancer risk in Lynch syndrome: a review - Bente A. Talseth-Palmer; Juul T. Wijnen; Desma M. Grice; Rodney J. Scott (Familial Cancer, 2013)

The role of epigenetics in Lynch syndrome - Megan P. Hitchins (Familial Cancer, 2013)

The InSiGHT database: utilizing 100 years of insights into Lynch Syndrome - J. P. Plazzer; R. H. Sijmons; M. O. Woods; P. Peltomäki; B. Thompson; J. T. Den Dunnen; F. Macrae (Familial Cancer, 2013)

Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistry - Jinru Shia; Susanne Holck; Giovanni DePetris; Joel K. Greenson; David S. Klimstra (Familial Cancer, 2013)

Role of new endoscopic techniques in Lynch syndrome - Jasmijn F. Haanstra; Jan H. Kleibeuker; Jan J. Koornstra (Familial Cancer, 2013)

EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients - Marjolijn J. L. Ligtenberg; Roland P. Kuiper; Ad Geurts van Kessel; Nicoline Hoogerbrugge (Familial Cancer, 2013)